140 related articles for article (PubMed ID: 11449844)
1. Itraconazole, terbinafine possibly linked to liver failure.
Am J Health Syst Pharm; 2001 Jun; 58(12):1076. PubMed ID: 11449844
[No Abstract] [Full Text] [Related]
2. Adverse drug reactions of the new oral antifungal agents--terbinafine, fluconazole, and itraconazole.
Amichai B; Grunwald MH
Int J Dermatol; 1998 Jun; 37(6):410-5. PubMed ID: 9646122
[No Abstract] [Full Text] [Related]
3. Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.
Nikkels AF; Nikkels-Tassoudji N; Piérard GE
Am J Clin Dermatol; 2006; 7(5):327-31. PubMed ID: 17007544
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis associated with terbinafine treatment.
Lowe G; Green C; Jennings P
BMJ; 1993 Jan; 306(6872):248. PubMed ID: 8443524
[No Abstract] [Full Text] [Related]
5. Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study.
Chiu HY; Chang WL; Tsai TF; Tsai YW; Shiu MN
Drug Saf; 2018 Mar; 41(3):285-295. PubMed ID: 29110252
[TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
Degreef H; del Palacio A; Mygind S; Ginter G; Pinto Soares A; Zuluaga de Cadena A
Acta Derm Venereol; 1999 May; 79(3):221-3. PubMed ID: 10384922
[TBL] [Abstract][Full Text] [Related]
7. Safety of itraconazole pulse therapy for onychomycosis. An update.
De Doncker P; Gupta AK; Cel Rosso JQ; Daniel CR; Rosen T; Verspeelt J; Marynissen G; Meuleneers L; Moskovitz B; Jacko M; Shear N; Odom RB; Aly R; Scher RK; Elewski BE
Postgrad Med; 1999 Jul; Spec No():17-25. PubMed ID: 10492662
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
9. Terbinafine-induced hepatitis and pancytopenia.
Conjeevaram G; Vongthavaravat V; Sumner R; Koff RS
Dig Dis Sci; 2001 Aug; 46(8):1714-6. PubMed ID: 11508672
[No Abstract] [Full Text] [Related]
10. Terbinafine hepatotoxicity: case report and review of the literature.
Fernandes NF; Geller SA; Fong TL
Am J Gastroenterol; 1998 Mar; 93(3):459-60. PubMed ID: 9517658
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
Kejda J
Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
[TBL] [Abstract][Full Text] [Related]
12. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Gupta AK; Gover MD; Lynde CW
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
[TBL] [Abstract][Full Text] [Related]
13. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
Angello JT; Voytovich RM; Jan SA
Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
[TBL] [Abstract][Full Text] [Related]
14. Advisory for fungal drugs.
FDA Consum; 2001; 35(4):4. PubMed ID: 11692887
[No Abstract] [Full Text] [Related]
15. [Antifungal drugs for pediatric use].
Nishimoto K
Nihon Ishinkin Gakkai Zasshi; 1999; 40(3):125-8. PubMed ID: 10423506
[TBL] [Abstract][Full Text] [Related]
16. Terbinafine-associated hepatic injury.
van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
[TBL] [Abstract][Full Text] [Related]
17. [Acute hepatitis associated with terbinafine].
Vivas S; Rodríguez M; Palacio MA; Cadenas F; Lomo J; Rodrigo L
Gastroenterol Hepatol; 1997 Nov; 20(9):456-8. PubMed ID: 9445740
[TBL] [Abstract][Full Text] [Related]
18. [Terbinafine induced hepatitis with persistent cholestasis].
Gendre G; Buclin T; Morard I; Fontannaz J; Berney JL
Rev Med Suisse; 2008 Mar; 4(149):736-9. PubMed ID: 18472735
[No Abstract] [Full Text] [Related]
19. [Terbinafine and cholestatic hepatitis].
Tejada García M; Llvona Hevia AM; Martín Arias L; García-Pando AC
Med Clin (Barc); 1997 Sep; 109(9):356. PubMed ID: 9379769
[No Abstract] [Full Text] [Related]
20. [Acute hepatitis related to the ingestion of terbinafine].
Vantaux P; Grasset D; Nougue J; Lagier E; Seigneuric C
Gastroenterol Clin Biol; 1996; 20(4):402-3. PubMed ID: 8758509
[No Abstract] [Full Text] [Related]
[Next] [New Search]
